Prognostic significance of carbonic anhydrase IX overexpression in stage III non-small cell lung cancer patients after neoadjuvant treatment

Ibis, Kamuran; Saglam, Sezer; Saglam, Esra; Firat, Pinar; Yilmazbayhan, Dilek; Toker, Alper; Ozkan, Berker; Hancer, Veysel; BUYUKDOGAN, Murat; Disci, Rian; Pilanci, Kezban

doi:10.1016/j.prp.2018.07.010

Prognostic significance of carbonic anhydrase IX overexpression in stage III non-small cell lung cancer patients after neoadjuvant treatment

Atıf İçin Kopyala

Ibis K., Saglam S., Saglam E. K., Firat P., Yilmazbayhan D., Toker A., ...Daha Fazla

PATHOLOGY RESEARCH AND PRACTICE, cilt.214, sa.9, ss.1291-1296, 2018 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 214 Sayı: 9
Basım Tarihi: 2018
Doi Numarası: 10.1016/j.prp.2018.07.010
Dergi Adı: PATHOLOGY RESEARCH AND PRACTICE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1291-1296
Anahtar Kelimeler: Non-small cell lung cancer (NSCLC), Carbonic anhydrase IX (CA DC), Neoadjuvant treatment, Prognosis, Overall survival, Disease free survival, POOR-PROGNOSIS, GENE-EXPRESSION, CA-IX, HYPOXIA, RADIOTHERAPY, CARCINOMA, PLASMA
İstanbul Üniversitesi Adresli: Evet

Özet

Background: To assess the prognostic importance of carbonic anhydrase IX (CA IX), a hypoxic biomarker, after neoadjuvant treatment in Stage III non-small cell lung cancer (NSCLC) patients.